Neurologic and Psychiatric Effects of SARS-CoV-2 Infection Meeting
The National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, and National Institute on Aging are conducting a virtual meeting, “Neurologic and Psychiatric Effects of SARS-CoV-2 Infection,” from July 14-15, 2021.
There is emerging data that in as high as 30 percent of COVID-19 patients, neurologic and psychiatric symptoms are observed. COVID-19 patients experience ischemic strokes, cerebral hemorrhages, encephalitis, prolonged unconsciousness and altered mental states (psychosis, delirium). Anxiety and post-traumatic stress disorders (PTSD) symptoms are also seen in these patients. A majority of patients also develop loss of smell and taste, myalgias and fatigue or malaise.
Many patients also experience Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
These include prolonged symptoms of fatigue, memory impairment, concentration disorder, headache, pain, insomnia, anxiety, PTSD, and depression. Pathologically there is controversy about detecting SARS-CoV-2 in the brain, and current thinking is that the virus does not infect the brain. However, there is strong evidence for microvascular disease, inflammation, and immune infiltration in the brain.
This meeting will examine emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other CNS infections such as HIV. A panel will convene to discuss future research gaps and priorities, particularly regarding long-term neurologic and psychiatric complications in relation to post-acute sequelae of SARS-CoV-2 (PASC).
More information and registration to come!